Notably, an elevated expression of NF-κB-dependent inflammatory genes is observed in the absence of the tumor suppressor p53.379 Studies suggest that NF-κB-driven chemokines may promote tumor progression, recurrence, and resistance to therapy. This evidence concerns the gene TP53 and neoplasm.